Company profile for Ensoma

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

At Ensoma, we believe every person, no matter where they are in the world, should have access to innovative technologies that are changing the way we treat disease. Ensoma was established in 2019 by 5AM Ventures and has assembled a highly experienced team with strong operational and gene therapy expertise. Harnessing the power of our Engenious™ vectors, we can deliver, for the first time, in vivo stem cell modification tech...
At Ensoma, we believe every person, no matter where they are in the world, should have access to innovative technologies that are changing the way we treat disease. Ensoma was established in 2019 by 5AM Ventures and has assembled a highly experienced team with strong operational and gene therapy expertise. Harnessing the power of our Engenious™ vectors, we can deliver, for the first time, in vivo stem cell modification technologies without the need for prior conditioning or stem cell collection.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
75 Kneeland St. 14th Floor Boston, MA 02111
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20251201792504/en/Ensoma-Announces-First-Patient-Dosed-in-Phase-12-Clinical-Trial-of-EN-374-for-Treatment-of-X-CGD

BUSINESSWIRE
01 Dec 2025

https://www.fiercebiotech.com/biotech/fierce-biotech-layoff-tracker-2025

FIERCE BIOTECH
21 Nov 2025
Genetic Medicines Biotech Halves Team
Genetic Medicines Biotech Halves Team

20 Nov 2025

// FIERCE BIOTECH

https://www.fiercebiotech.com/biotech/ensoma-halves-workforce-after-transitioning-genetic-medicine-clinic

FIERCE BIOTECH
20 Nov 2025

https://www.businesswire.com/news/home/20251104872316/en/Ensoma-Presents-Preclinical-Data-Demonstrating-Potential-of-In-Vivo-HSC-derived-CAR-M-NK-and-T-Platform-for-Solid-Tumors-at-SITC-2025

BUSINESSWIRE
04 Nov 2025

https://www.businesswire.com/news/home/20251003145265/en/Ensoma-to-Present-New-Preclinical-Data-at-the-Society-for-Immunotherapy-of-Cancer-Annual-Meeting

BUSINESSWIRE
03 Oct 2025

https://www.businesswire.com/news/home/20250922010282/en/Ensoma-Announces-%2453-Million-Financing-to-Support-Key-Clinical-Milestones-for-EN-374-and-Continued-Development-of-In-Vivo-Hematopoietic-Stem-Cell-Engineering-Pipeline

BUSINESSWIRE
22 Sep 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty